However, mutations in CYP11A gene were subsequently reported resulting in indistinguishable clinical and hormonal phenotypes when compared to LCAH cases (Tajima et al., 2001; Katsumata et al., 2002; Hiort et al., 2005). This evidence concerns the gene CYP11A1 and congenital lipoid adrenal hyperplasia due to STAR deficency.